Cite
Generation and Clinical Application of Gene-Modified Autologous Epidermal Sheets in Netherton Syndrome: Lessons Learned from a Phase 1 Trial.
MLA
Di, Wei-Li, et al. “Generation and Clinical Application of Gene-Modified Autologous Epidermal Sheets in Netherton Syndrome: Lessons Learned from a Phase 1 Trial.” Human Gene Therapy, vol. 30, no. 9, Sept. 2019, pp. 1067–78. EBSCOhost, https://doi.org/10.1089/hum.2019.049.
APA
Di, W.-L., Lwin, S. M., Petrova, A., Bernadis, C., Syed, F., Farzaneh, F., Moulding, D., Martinez, A. E., Sebire, N. J., Rampling, D., Virasami, A., Zamiri, M., Wang, W., Hara, H., Kadiyirire, T., Abdul-Wahab, A., Martinez-Queipo, M., Harper, J. I., McGrath, J. A., … Qasim, W. (2019). Generation and Clinical Application of Gene-Modified Autologous Epidermal Sheets in Netherton Syndrome: Lessons Learned from a Phase 1 Trial. Human Gene Therapy, 30(9), 1067–1078. https://doi.org/10.1089/hum.2019.049
Chicago
Di, Wei-Li, Su M Lwin, Anastasia Petrova, Catina Bernadis, Farhatullah Syed, Farzin Farzaneh, Dale Moulding, et al. 2019. “Generation and Clinical Application of Gene-Modified Autologous Epidermal Sheets in Netherton Syndrome: Lessons Learned from a Phase 1 Trial.” Human Gene Therapy 30 (9): 1067–78. doi:10.1089/hum.2019.049.